Increased number of circulating exosomes and their microRNA cargos are potential novel biomarkers in alcoholic hepatitis

Journal of Translational Medicine

Volumn 13, Issue 1, 2015, Pages

  Momen Heravi, Fatemeh ^a   Saha, Banishree ^a   Kodys, Karen ^a   Catalano, Donna ^a   Satishchandran, Abhishek ^a   Szabo, Gyongyi ^a  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

Acute alcoholic hepatitis; Alcohol; Biomarker; Exosomes; Extracellular vesicles; Human; Liquid biopsy; Liver injury; Microvesicles; miRNA

Indexed keywords

ALCOHOL; MICRORNA; MICRORNA 122; MICRORNA 1246; MICRORNA 192; MICRORNA 30A; MICRORNA 30B; MICRORNA 744; UNCLASSIFIED DRUG; ALANINE AMINOTRANSFERASE; BIOLOGICAL MARKER;

ALCOHOL LIVER DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL ISOLATION; CELL SUBPOPULATION; CLINICAL ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; EXOSOME; FEMALE; HUMAN; HUMAN CELL; MICROARRAY ANALYSIS; MOUSE; NONHUMAN; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; TRANSMISSION ELECTRON MICROSCOPY; UPREGULATION; WESTERN BLOTTING; ANIMAL; BLOOD; C57BL MOUSE; CASE CONTROL STUDY; FEEDING BEHAVIOR; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; RNA STABILITY; SOFTWARE; ULTRASTRUCTURE;

ALANINE TRANSAMINASE; ANIMALS; BIOMARKERS; CASE-CONTROL STUDIES; ETHANOL; EXOSOMES; FEEDING BEHAVIOR; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HEPATITIS, ALCOHOLIC; HUMANS; MICE, INBRED C57BL; MICRORNAS; RNA STABILITY; ROC CURVE; SOFTWARE;

EID: 84938851669     PISSN: None     EISSN: 14795876     Source Type: Journal    
DOI: 10.1186/s12967-015-0623-9     Document Type: Article

References (47)

1. Orman ES, Odena G, Bataller R (2013) Alcoholic liver disease: pathogenesis, management, and novel targets for therapy. J Gastroenterol Hepatol 28(Suppl 1):77-84
2. Ozer J, Ratner M, Shaw M, Bailey W, Schomaker S (2008) The current state of serum biomarkers of hepatotoxicity. Toxicology 245:194-205
3. Kim WR, Flamm SL, Di Bisceglie AM, Bodenheimer HC (2008) Serum activity of alanine aminotransferase (ALT) as an indicator of health and disease. Hepatology 47:1363-1370
4. Iorio MV, Croce CM (2009) MicroRNAs in cancer. J Clin Oncol 27:5848-5856
5. Farazi TA, Spitzer JI, Morozov P, Tuschl T (2011) miRNAs in human cancer. J Pathol 223:102-115
6. Momen-Heravi F, Trachtenberg AJ, Kuo WP, Cheng YS (2014) Genomewide study of salivary microRNAs for detection of oral cancer. J Dent Res 93:86S-93S
7. Akat KM, Moore-McGriff D, Morozov P, Brown M, Gogakos T, Correa Da Rosa J et al (2014) Comparative RNA-sequencing analysis of myocardial and circulating small RNAs in human heart failure and their utility as biomarkers. Proc Natl Acad Sci USA 111:11151-11156
8. Bekris LM, Leverenz JB (2015) The biomarker and therapeutic potential of miRNA in Alzheimer's disease. Neurodegener Dis Manag 5:61-74
9. How CK, Hou SK, Shih HC, Huang MS, Chiou SH, Lee CH et al (2015) Expression profile of microRNAs in gram-negative bacterial sepsis. Shock 43:121-127
10. He L, Hannon GJ (2004) MicroRNAs: small RNAs with a big role in gene regulation. Nat Rev Genet 5:522-531
11. Gibbings D, Mostowy S, Jay F, Schwab Y, Cossart P, Voinnet O (2012) Selective autophagy degrades DICER and AGO2 and regulates miRNA activity. Nat Cell Biol 14:1314-1321
12. Povero D, Eguchi A, Li H, Johnson CD, Papouchado BG, Wree A et al (2014) Quantification and size-profiling of extracellular vesicles using tunable resistive pulse sensing. J Vis Exp 92:e51623
13. Cote GA, Gore AJ, McElyea SD, Heathers LE, Xu H, Sherman S et al (2014) A pilot study to develop a diagnostic test for pancreatic ductal adenocarcinoma based on differential expression of select miRNA in plasma and bile. Am J Gastroenterol 109:1942-1952
14. Sheinerman KS, Umansky SR (2013) Circulating cell-free microRNA as biomarkers for screening, diagnosis and monitoring of neurodegenerative diseases and other neurologic pathologies. Front Cell Neurosci 7:150
15. Jia S, Zocco D, Samuels ML, Chou MF, Chammas R, Skog J et al (2014) Emerging technologies in extracellular vesicle-based molecular diagnostics. Exp Rev Mol Diagn 14:307-321
16. Momen-Heravi F, Balaj L, Alian S, Trachtenberg AJ, Hochberg FH, Skog J et al (2012) Impact of biofluid viscosity on size and sedimentation efficiency of the isolated microvesicles. Front Physiol 3:162
17. Momen-Heravi F, Bala S, Bukong T, Szabo G (2014) Exosome-mediated delivery of functionally active miRNA-155 inhibitor to macrophages. Nanomedicine 10:1517-1527
18. Cheng L, Sharples RA, Scicluna BJ, Hill AF (2014) Exosomes provide a protective and enriched source of miRNA for biomarker profiling compared to intracellular and cell-free blood. J Extracell Vesicles 3:10
19. Povero D, Eguchi A, Li H, Johnson CD, Papouchado BG, Wree A et al (2014) Circulating extracellular vesicles with specific proteome and liver microRNAs are potential biomarkers for liver injury in experimental fatty liver disease. PLoS One 9:e113651
20. Arrese M, Eguchi A, Feldstein AE (2015) Circulating microRNAs: emerging biomarkers of liver disease. Semin Liver Dis 35:43-54
21. O'Shea RS, Dasarathy S, McCullough AJ, Practice Guideline Committee of the American Association for the Study of Liver Diseases, Practice Parameters Committee of the American College of Gastroenterology (2010) Alcoholic liver disease. Hepatology 51:307-328
22. Petrasek J, Iracheta-Vellve A, Saha B, Satishchandran A, Kodys K, Fitzgerald KA et al (2015) Metabolic danger signals, uric acid and ATP, mediate inflammatory cross-talk between hepatocytes and immune cells in alcoholic liver disease. J Leukoc Biol 98:249-256
23. Andersen CL, Jensen JL, Ørntoft TF (2004) Normalization of real-time quantitative reverse transcription-PCR data: a model-based variance estimation approach to identify genes suited for normalization, applied to bladder and colon cancer data sets. Cancer Res 64:5245-5250
24. Nath B, Levin I, Csak T, Petrasek J, Mueller C, Kodys K et al (2011) Hepatocyte-specific hypoxia-inducible factor-1aα is a determinant of lipid accumulation and liver injury in alcohol-induced steatosis in mice. Hepatology 53:1526-1537
25. Momen-Heravi F, Balaj L, Alian S, Tigges J, Toxavidis V, Ericsson M et al (2012) Alternative methods for characterization of extracellular vesicles. Front Physiol 3:354
26. Leung TM, Lu Y, Yan W, Morón-Concepción JA, Ward SC, Ge X et al (2012) Argininosuccinate synthase conditions the response to acute and chronic ethanol-induced liver injury in mice. Hepatology 55:1596-1609
27. Momen Heravi F, Bala S, Kodys K, Szabo G (2015) Exosomes derived from alcohol-treated hepatocytes horizontally transfer liver specific miRNA-122 and sensitize monocytes to LPS. Sci Rep 5:9991
28. Momen-Heravi F, Balaj L, Alian S, Mantel PY, Halleck AE, Trachtenberg AJ et al (2013) Current methods for the isolation of extracellular vesicles. Biol Chem 394:1253-1262
29. Bukong TN, Momen-Heravi F, Kodys K, Bala S, Szabo G (2014) Exosomes from hepatitis C infected patients transmit HCV infection and contain replication competent viral RNA in complex with Ago2-miR122-HSP90. PLoS Pathog 10:e1004424
30. Masyuk AI, Masyuk TV, Larusso NF (2013) Exosomes in the pathogenesis, diagnostics and therapeutics of liver diseases. J Hepatol 59:621-625
31. Rodríguez-Suárez E, Gonzalez E, Hughes C, Conde-Vancells J, Rudella A, Royo F et al (2014) Quantitative proteomic analysis of hepatocyte-secreted extracellular vesicles reveals candidate markers for liver toxicity. J Proteom 103:227-240
32. Raposo G, Stoorvogel W (2013) Extracellular vesicles: exosomes, microvesicles, and friends. J Cell Biol 200:373-383
33. Trajkovic K, Hsu C, Chiantia S, Rajendran L, Wenzel D, Wieland F et al (2008) Ceramide triggers budding of exosome vesicles into multivesicular endosomes. Science 319:1244-1247
34. Théry C, Boussac M, Véron P, Ricciardi-Castagnoli P, Raposo G, Garin J et al (2001) Proteomic analysis of dendritic cell-derived exosomes: a secreted subcellular compartment distinct from apoptotic vesicles. J Immunol 166:7309-7318
35. Akers JC, Ramakrishnan V, Kim R, Skog J, Nakano I, Pingle S et al (2013) miR-21 in the extracellular vesicles (EVs) of cerebrospinal fluid (CSF): a platform for glioblastoma biomarker development. PLoS One 8:e78115
36. Fujita Y, Kuwano K, Ochiya T, Takeshita F (2014) The impact of extracellular vesicle-encapsulated circulating microRNAs in lung cancer research. Biomed Res Int 2014:486413
37. Turchinovich A, Weiz L, Langheinz A, Burwinkel B (2011) Characterization of extracellular circulating microRNA. Nucleic Acids Res 39:7223-7233
38. Mathivanan S, Ji H, Simpson RJ (2010) Exosomes: extracellular organelles important in intercellular communication. J Proteom 73:1907-1920
39. Boukouris S, Mathivanan S (2015) Exosomes in bodily fluids are a highly stable resource of disease biomarkers. Proteom Clin Appl 9:358-367
40. Caradec J, Kharmate G, Hosseini-Beheshti E, Adomat H, Gleave M, Guns E (2014) Reproducibility and efficiency of serum-derived exosome extraction methods. Clin Biochem 47:1286-1292
41. Hou J, Lin L, Zhou W, Wang Z, Ding G, Dong Q et al (2011) Identification of miRNomes in human liver and hepatocellular carcinoma reveals miR-199a/b-3p as therapeutic target for hepatocellular carcinoma. Cancer Cell 19:232-243
42. Bala S, Petrasek J, Mundkur S, Catalano D, Levin I, Ward J et al (2012) Circulating microRNAs in exosomes indicate hepatocyte injury and inflammation in alcoholic, drug-induced, and inflammatory liver diseases. Hepatology 56:1946-1957
43. Postigo AA, Depp JL, Taylor JJ, Kroll KL (2003) Regulation of Smad signaling through a differential recruitment of coactivators and corepressors by ZEB proteins. EMBO J 22:2453-2462
44. Klein S, Rick J, Schierwagen R, Uschner FE, Strassburg CP, Laleman W et al (2014) Jak2/Arhgef1 signaling correlates with severity of liver disease and represents a target for therapy of portal hypertension. Hepatology 60(S1):302A-304A
45. Small EM, Frost RJ, Olson EN (2010) MicroRNAs add a new dimension to cardiovascular disease. Circulation 121:1022-1032
46. Piano MR (2002) Alcoholic cardiomyopathy: incidence, clinical characteristics, and pathophysiology. Chest 121:1638-1650
47. Alexander J, Mishra P, Desai N, Ambadekar S, Gala B, Sawant P (2007) Cirrhotic cardiomyopathy: Indian scenario. J Gastroenterol Hepatol 22:395-399